Q Bio

Offers preventive health assessments and monitoring

San Carlos, California, United States

About Q Bio

Q.bio specializes in preventive medicine by detecting early signs of disease before symptoms occur, which allows for timely interventions. Their main product, the Q Exam, collects health data from various sources and stores it in a personalized BioVault, accessible through a telemedicine-friendly Q Dashboard. Unlike competitors, Q.bio offers a comprehensive health assessment and a subscription model for continuous monitoring, empowering clients to manage their health proactively. The company's goal is to transform healthcare by providing detailed insights that facilitate early disease detection.

San Carlos, CaliforniaHeadquarters

2015Year Founded

$65.2MTotal Funding

LATE_VCCompany Stage

HealthcareIndustries

11-50Employees

Risks

TFM technology may face slow adoption due to entrenched traditional MRI systems.

Reliance on venture capital funding poses financial risks if future rounds falter.

Intensifying competition in preventive healthcare could impact Q Bio's market share.

Differentiation

Q Bio's Tensor Field Mapping offers quantitative data, unlike traditional qualitative MRIs.

The Q Exam provides a comprehensive health assessment in just one hour.

Q Bio's BioVault ensures secure storage of personal health data.

Upsides

AI integration in MRI technology complements Q Bio's Tensor Field Mapping.

The rise of personalized medicine boosts demand for Q Bio's health assessments.

Telemedicine integration aligns with Q Bio's subscription model for regular assessments.

Funding

Total raised$65.17 M

Latest valuation$200.00 M

StageLATE_VC

LATE VC

6/30/2024

$27

$200.00 M

SERIES B

2/29/2020

$40